A Study to Investigate the Influence of PTH-lowering by Etelcalcetide (Parsabiv®) on the Calcification Propensity of Serum in Dialysis Patients
Clinical trial NCT03795558 · COMPLETED
Trial details
- NCT number
- NCT03795558
- Sponsor
- Prim. Priv. Doz. Dr. Daniel Cejka
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2021-12-21
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.